A detailed history of Prosperitas Financial LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Prosperitas Financial LLC holds 13,566 shares of ABBV stock, worth $2.41 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares
13,566
Previous 12,681 6.98%
Holding current value
$2.41 Million
Previous $2.18 Billion 23.16%
% of portfolio
1.44%
Previous 1.33%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$163.84 - $199.33 $144,998 - $176,407
885 Added 6.98%
13,566 $2.68 Billion
Q2 2024

Oct 29, 2024

BUY
$154.79 - $180.76 $1.96 Million - $2.29 Million
12,681 New
12,681 $2.18 Billion
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $165,893 - $189,019
1,038 Added 9.39%
12,088 $2.2 Billion
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $171,036 - $192,627
1,243 Added 12.67%
11,050 $1.71 Billion
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $1.31 Million - $1.52 Million
9,807 New
9,807 $1.46 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Prosperitas Financial LLC Portfolio

Follow Prosperitas Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosperitas Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prosperitas Financial LLC with notifications on news.